文献速递产科

剖宫产术后皮肤缝合中皮下缝线类型的比较:一项随机对照试验

Comparison of Subcuticular Suture Type for Skin Closure After Cesarean Delivery: A Randomized Controlled Trial.
PubMed 文献 · Obstet Gynecol · 2017-01-01

该随机对照试验将≥37周行非急诊剖宫产且采用Pfannenstiel切口皮下缝合的产妇随机分为聚卡普隆25缝线组与聚乳酸羟基乙酸910缝线组,主要结局为产后30天内伤口并发症复合结局。聚卡普隆25组总体伤口并发症发生率8.8%,显著低于聚乳酸羟基乙酸910组的14.4%(相对风险0.61,95%CI 0.37-0.99;P=.04)。结论认为聚卡普隆25缝线可降低剖宫产术后伤口并发症发生率。

要点

  • 聚卡普隆25组伤口并发症8.8%,聚乳酸羟基乙酸910组14.4%,相对风险0.61(95%CI 0.37-0.99;P=.04)。
  • 主要结局为产后30天内手术部位感染、伤口裂开、血肿或血清肿的复合结局。

核心结论

  • 剖宫产术后采用聚卡普隆25缝线缝合皮肤,与聚乳酸羟基乙酸910缝线相比可降低伤口并发症发生率。

研究设计与样本

  • 随机对照试验,纳入≥37周行非急诊剖宫产且采用Pfannenstiel皮肤切口皮下缝合的产妇,随机分为聚卡普隆25组与聚乳酸羟基乙酸910组。
  • 为检测主要结局发生率从12%降至4%,把握度0.90、双侧α=0.05,每组需237例。
  • 按意向性治疗原则分析。

主要发现

  • 聚卡普隆25组总体伤口并发症发生率为8.8%,聚乳酸羟基乙酸910组为14.4%(相对风险0.61,95%CI 0.37-0.99;P=.04)。
  • 两组人口学特征、合并症及围手术期特征相似。
  • 主要结局为产后30天内手术部位感染、伤口裂开、血肿或血清肿中一项或以上的复合结局。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the rate of wound complications among women who underwent cesarean delivery through a Pfannenstiel skin incision followed by subcuticular closure with either poliglecaprone 25 suture or polyglactin 910 suture. METHODS: Patients undergoing nonemergent cesarean delivery at or beyond 37 weeks of gestation were randomized to undergo subcuticular skin closure with either poliglecaprone 25 or polyglactin 910. The primary outcome was a wound composite outcome of one or more of the following: surgical site infection, wound separation, hematoma, or seroma within the first 30 days postpartum. To detect a reduction in the primary outcome rate from 12% to 4%, with a power of 0.90 and a two-tailed α of 0.05, 237 women per study group were required. Analysis was performed according to the intent-to-treat principle. RESULTS: From May 28, 2015, to August 5, 2016, 275 women were randomized to poliglecaprone 25 and 275 to polyglactin 910, of whom 520 (95%) were included in the final analysis: 263 in the poliglecaprone 25 group [of whom 231 (88%) actually underwent poliglecaprone 25 closure) and 257 in the polyglactin 910 group [of whom 209 (81%) actually underwent polyglactin 910 closure]. The groups were similar in demographic characteristics, medical comorbidities, and perioperative characteristics. Poliglecaprone 25 was associated with a significantly decreased rate of overall wound complications when compared with polyglactin 910, 8.8% compared with 14.4% (relative risk 0.61, 95% CI 0.37-0.99; P=.04). CONCLUSION: Closure of the skin after cesarean delivery with poliglecaprone 25 suture decreases the rate of wound complications compared with polyglactin 910 suture. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, NCT02459093.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Buresch AM, Van Arsdale A, Ferzli M, et al. Comparison of Subcuticular Suture Type for Skin Closure After Cesarean Delivery: A Randomized Controlled Trial. Obstet Gynecol. 2017. PMID: 28796687. doi:10.1097/AOG.0000000000002200

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。